SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 68 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $537 | -99.9% | 606,023 | +8.7% | 0.00% | 0.0% |
| Q3 2022 | $875,000 | -16.7% | 557,591 | +6.6% | 0.00% | -50.0% |
| Q2 2022 | $1,051,000 | +45.6% | 522,863 | +68.8% | 0.00% | +100.0% |
| Q1 2022 | $722,000 | -49.0% | 309,702 | +1.7% | 0.00% | -50.0% |
| Q4 2021 | $1,415,000 | -37.9% | 304,405 | +1.9% | 0.00% | -33.3% |
| Q3 2021 | $2,279,000 | -19.3% | 298,752 | +2.5% | 0.00% | -25.0% |
| Q2 2021 | $2,824,000 | +20.9% | 291,417 | +3.2% | 0.00% | +33.3% |
| Q1 2021 | $2,336,000 | +16.4% | 282,514 | -3.9% | 0.00% | 0.0% |
| Q4 2020 | $2,007,000 | -27.8% | 294,032 | +18.0% | 0.00% | -25.0% |
| Q3 2020 | $2,778,000 | +68.1% | 249,179 | -5.3% | 0.00% | +33.3% |
| Q2 2020 | $1,653,000 | +451.0% | 263,261 | +61.5% | 0.00% | +200.0% |
| Q1 2020 | $300,000 | -45.8% | 162,965 | -0.5% | 0.00% | 0.0% |
| Q4 2019 | $554,000 | +64.9% | 163,774 | +4.5% | 0.00% | 0.0% |
| Q3 2019 | $336,000 | -19.2% | 156,776 | +0.7% | 0.00% | 0.0% |
| Q2 2019 | $416,000 | -37.2% | 155,636 | +11.6% | 0.00% | 0.0% |
| Q1 2019 | $662,000 | +100.6% | 139,448 | +1.3% | 0.00% | 0.0% |
| Q4 2018 | $330,000 | -10.3% | 137,637 | +64.7% | 0.00% | 0.0% |
| Q3 2018 | $368,000 | -35.9% | 83,565 | +4.9% | 0.00% | 0.0% |
| Q2 2018 | $574,000 | +319.0% | 79,692 | +129.8% | 0.00% | – |
| Q1 2017 | $137,000 | -12.7% | 34,686 | +8.4% | 0.00% | – |
| Q4 2016 | $157,000 | -32.9% | 32,000 | +5.7% | 0.00% | -100.0% |
| Q3 2016 | $234,000 | +39.3% | 30,275 | +1.0% | 0.00% | – |
| Q2 2016 | $168,000 | +6.3% | 29,975 | +2.0% | 0.00% | – |
| Q1 2016 | $158,000 | -37.8% | 29,400 | +0.8% | 0.00% | -100.0% |
| Q4 2015 | $254,000 | +21.0% | 29,170 | +16.4% | 0.00% | 0.0% |
| Q3 2015 | $210,000 | -50.2% | 25,060 | +4.6% | 0.00% | 0.0% |
| Q2 2015 | $422,000 | – | 23,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,711,063 | $14,355,000 | 5.36% |
| Avoro Capital Advisors LLC | 2,151,437 | $18,051,000 | 4.69% |
| Cormorant Asset Management, LP | 2,095,334 | $17,580,000 | 2.81% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,517,000 | 1.46% |
| AlpInvest Partners B.V. | 86,540 | $726,000 | 1.43% |
| Healthcare Value Capital, LLC | 50,000 | $420,000 | 0.60% |
| Aisling Capital LLC | 353,855 | $2,969,000 | 0.52% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $168,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 51,582 | $433,000 | 0.21% |
| Spark Investment Management LLC | 106,400 | $891,000 | 0.12% |